| 发明名称 |
Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules |
| 摘要 |
The present invention provides use of soluble CTLA4 mutant molecules which bind with greater avidity to the CD80 and/or CD86 antigen than wild type CTLA4 or non-mutated CTLA4Ig in the treatment of immune disorders associated with graft transplantation. |
| 申请公布号 |
US7482327(B2) |
申请公布日期 |
2009.01.27 |
| 申请号 |
US20060399666 |
申请日期 |
2006.04.06 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
HAGERTY DAVID;RUSNAK JAMES |
| 分类号 |
A61K38/16 |
主分类号 |
A61K38/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
